Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Efficacy and safety of immunotherapy in elderly patients with non-small cell lung cancer.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Efficacy and safety of immunotherapy in elderly patients with non-small cell lung cancer.
Efficacy and safety of immunotherapy in elderly patients with non-small cell lung cancer. Lung Cancer. 2019 11; 137:38-42.
View in:
PubMed
subject areas
Aged
Aged, 80 and over
Antineoplastic Agents, Immunological
Carcinoma, Non-Small-Cell Lung
Carcinoma, Squamous Cell
Female
Follow-Up Studies
Humans
Immunotherapy
Lung Neoplasms
Male
Patient Safety
Prognosis
Response Evaluation Criteria in Solid Tumors
Retrospective Studies
Survival Rate
authors with profiles
Marina Chiara Garassino